Establishment and characterization of a cell line of human breast carcinoma origin.

Suppr

超能文献

作者信息

Keydar I, Chen L, Karby S, Weiss F R, Delarea J, Radu M, Chaitcik S, Brenner H J

出版信息

Eur J Cancer (1965). 1979 May;15(5):659-70. doi: 10.1016/0014-2964(79)90139-7.

DOI:10.1016/0014-2964(79)90139-7

PMID:228940

Abstract

摘要

相似文献

Establishment and characterization of a cell line of human breast carcinoma origin.

Eur J Cancer (1965). 1979 May;15(5):659-70. doi: 10.1016/0014-2964(79)90139-7.

Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.

Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.

Comparison of two score systems in Bcl-2 and Bax protein expression in invasive ductal carcinoma of breast and relation with oestrogen and progestrone receptors.

Breast J. 2009 May-Jun;15(3):310-2. doi: 10.1111/j.1524-4741.2009.00727.x.

Estrogen, progesterone, and Her-2/neu receptor expression discrepancy in primary tumors and in-breast relapse in patients with breast cancer.

Breast J. 2014 May-Jun;20(3):322-4. doi: 10.1111/tbj.12270. Epub 2014 Apr 11.

Immunohistochemical analysis of the topographical relationship between the estrogen- and progesterone receptor in five human breast cancers. A simultaneous demonstration of both nuclear receptors in the same section by using a computer-assisted image processing.

Virchows Arch A Pathol Anat Histopathol. 1989;414(4):339-44. doi: 10.1007/BF00734089.

Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.

Histopathology. 2007 Jun;50(7):866-74. doi: 10.1111/j.1365-2559.2007.02687.x.

The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern.

Am J Surg. 2007 Aug;194(2):272-3. doi: 10.1016/j.amjsurg.2006.07.022.

Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast.

Int J Biol Markers. 2015 Nov 11;30(4):e425-8. doi: 10.5301/jbm.5000163.

Correlation of hormone receptors with pathological features in human breast cancer.

Cancer. 1980 Dec 15;46(12 Suppl):2869-71. doi: 10.1002/1097-0142(19801215)46:12+<2869::aid-cncr2820461426>3.0.co;2-q.

Estrogen control of lactate dehydrogenase isoenzyme-5 in human breast cancer.

Int J Cancer. 1988 Jan 15;41(1):10-6. doi: 10.1002/ijc.2910410104.

引用本文的文献

Insights on the differences between two‑ and three‑dimensional culture systems in tumor models (Review).

Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5626. Epub 2025 Sep 5.

Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer.

Mar Drugs. 2024 Oct 5;22(10):459. doi: 10.3390/md22100459.

Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.

BMC Cancer. 2024 Mar 14;24(1):339. doi: 10.1186/s12885-024-11979-3.

Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.

PLoS One. 2024 Feb 26;19(2):e0297080. doi: 10.1371/journal.pone.0297080. eCollection 2024.

Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes.

Cells. 2024 Feb 6;13(4):301. doi: 10.3390/cells13040301.

Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway.

J Transl Med. 2024 Jan 3;22(1):15. doi: 10.1186/s12967-023-04841-w.

Comparison of Three Low-Molecular-Weight Fluorescent Probes for Measuring Free Zinc Levels in Cultured Mammary Cells.

Nutrients. 2023 Apr 13;15(8):1873. doi: 10.3390/nu15081873.

extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist.

Front Pharmacol. 2023 Mar 13;14:1122031. doi: 10.3389/fphar.2023.1122031. eCollection 2023.

Effects of β-caryophyllene and oxygen availability on cholesterol and fatty acids in breast cancer cells.

PLoS One. 2023 Mar 9;18(3):e0281396. doi: 10.1371/journal.pone.0281396. eCollection 2023.

Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses.

Front Oncol. 2023 Jan 16;12:1015708. doi: 10.3389/fonc.2022.1015708. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验